    |
||
|
xxx |
Sam Turco Research Interests Protozoan parasites of the genus Leishmania are responsible for a spectrum of human diseases, termed leishmaniasis. Depending on the species involved, leishmaniasis appears clinically in three forms: cutaneous, mucocutaneous and visceral, the last being fatal if untreated. The parasites have a remarkable capacity to avoid destruction in the hostile environments encountered in their life cycle, alternating between intracellular macrophage parasitism and extracellular life in the gut of the sand fly vector. As in other microbial pathogens, the development of genetic tools for the study of these parasites promises to help unravel the molecular details of how these microorganisms persevere under such harsh circumstances. Advances in functional genetic analysis provide a new avenue for identifying genes implicated in the parasite’s infectious cycle, such as those necessary for the synthesis and expression of the key surface virulence factor, lipophosphoglycan (LPG). LPG has been implicated in binding and release of the parasite in the midgut of the sand fly, resistance to complement, binding and uptake by macrophages, modulating macrophage signal transduction, resistance to oxidative attack, and, ultimately, allowing the parasite to establish successful infections. The overall objective of our research is to elucidate the genetic and biochemical details of the biosynthesis of the Leishmania lipophosphoglycan and related glycoconjugates, primarily through the exploitation of LPG-defective mutants using forward/reverse genetic protocols. This work is collaborative effort with Dr. Stephen Beverley (Washington Univ. Sch. Med). The functions of the proteins encoded by LPG genes recovered by genomic and bioinformatic approaches is a primary focus of our laboratory. These functions and eventual characterization of the encoded proteins will be determined through the development and use of in vitro enzymatic assays. From our studies, we hope to contribute to the understanding of the role glycoconjugates play in the pathogenesis of leishmaniasis and to provide a biochemical rationale for the design of chemotherapeutic regimens that exploit complex carbohydrate differences between those of the mammalian host and of the parasite. PUBLICATIONS SINCE 2004 (out of 150) Kamhawi, S., Ramalho-Ortigao, M., Pham, V. M., Kumar, S., Lawyer, P. G., Turco, S. J., Barillas-Mury, C., Sacks, D. L., and Valenzuela, J. G., A Role for Insect Galectins in Parasite Survival. (2004) Cell 119, 1-20 Zhang, K., Barron, T., Turco, S. J., Beverley, S. M., The LPG1 Gene Family of Leishmania major. (2004) Mol. Biochem. Parasitol., 136, 11-23. Spath, G. F., Fye, L., Segawa, H., Turco, S. J., and Beverley, S. J., Identification of a Compensatory Mutant (lpg2-REV) in Leishmania major able to Survive as Amastigotes within Macrophages without LPG2-dependent Glycoconjugates, and its Significance to Virulence and Immunization Strategies. (2004) Infect. Immun., 72, 3622-3677. Soares, R. P.P., Barron, T., McCoy-Simandle, K., Svobodova, M., Warburg, A., and Turco, S. J., Leishmania tropica: Intraspecific Polymorphisms in Lipophosphoglycan Correlate with Transmission by Different Phlebotomus Species. (2004) Exp. Parasitol., 107, 105-114. Tonui, W. K., Ngumbi, P. M., Mpoke, S. S., Orago, A. S., Mbati, P. A., Turco, S. J., and Mkoji, G. M., Leishmania major-Phlebotomus duboscqi interactions: Inhibition of anti-LPG antibodies and characterisation of two proteins with shared epitopes. (2004) East Afr. Med. Journal 81, 97-103. Colmenares, M., Corbi, A. L., Turco, S. J., and Rivas, L., The Dendritic Cell Receptor DC-SIGN Discriminates among Species and Life Cycle Forms of Leishmania. (2004) Journal of Immunology 172, 1186-1190. Amprey, J. L., Im, J. S., Turco, S. J., Murray, H., Illarionov, P. A., Besra, G. S., Porcelli, S., and Spath, G., F., A Subset of Liver NK T Cells is Activated during Leishmania donovani Infection by CD1d-bound Lipophosphoglycan. (2004) J. Exp. Med., 200, 895-904. Soares, R. P. P., Cardoso, T. L., Barron, T., Araujo, M. S., Pimenta, P. L., and Turco, S. J., Leishmania braziliensis: A Novel Mechanism in the LPG Regulation during Metacyclogenesis. (2005) Int. J. Parasitol., 35, 245-253. Segawa, H., Soares, R. P. P., Kawakita, M., Beverley, S. M., and Turco, S. J., Reconstitution of GDP-Man Transport Activity with Purified Leishmania LPG2 Protein in Liposomes. (2005) J. Biol. Chem., 280, 2028-2035. Dermine, J. F., Goyette, G., Houde, M., Turco, S. J., and Desjardins, M., Leishmania donovani lipophosphoglycan disrupts phagosome microdomains in J774 macrophages. (2005) Cellular Microbiol., 7, 1263-1270. Barron, T., and Turco, S. J., Quantitation of Leishmania Lipophosphoglycan Repeat Units by Capillary Electrophoresis. (2006) Biochem. Biophys. Acta, 1760, 710-714.. Dobson, D. E., Scholtes, L. D., Myler, P. J., Turco, S. J., and Beverley, S. M., The Genomic Organization of the Expanded SCG Gene Family of Leishmania major: Telomeric and Internal Clusters of Genes Related to those Mediating Species-Specific and Developmental LPG Modifications. (2006) Mol. Biochem. Parasitol., 146, 231-241. Goswami, M., Dobson, D. E., Beverley, S. M., and Turco, S. J., Demonstration by Heterologous Expression that the Leishmania SCA1 Gene encodes an Arabinosyltransferase. (2006) Glycobiology, 16, 230-236. Kavoosi, G., Ardestani, S. K., Kariminia, A., Abolhassani, M., Turco, S. J., Leishmania major: ROS and IFN-g Induction by soluble Lipophosphoglycan of Stationary Phase Promastigotes. (2006) Exp. Parasitol., 114, 323-328. Capul, A. A., Barron, T., Dobson, D. E., Turco, S. J., and Beverley, S. M., Two Functionally Divergent UDP-Gal Transporters Participate in Phosphoglycan Synthesis in Leishmania major. (2007) J. Biol. Chem., 282, 14006-14017. |
